PFE | Pfizer Inc

CUSIP: 717081103

6 Funds Holding
7.7M Total Shares
$184M Total Value
$28.02
Price
$159.7B
Market Cap
37.4
P/E Ratio
9.7
Forward P/E
$0.75
EPS (TTM)
6.08%
Dividend Yield
$11.7B
Cash
$64.0B
Total Debt
5.70B
Shares Out
$23.58
$28.75
52-Week Range

Institutional Ownership of Pfizer Inc

Fund / Manager Click to search
Shares Value % of Portfolio Cost Basis Est. Return
3.8M $92M
2.83%
$26.62 +5.27%
1.9M $46M
0.50%
$27.52 -2.34%
1.0M $25M
0.95%
$31.12 -13.88%
Kahn Brothers Group|Thomas Kahn
464.0K $11M
1.77%
231.0K $6M
0.37%
$26.14 +2.85%
174.6K $4M
3.04%
$28.73 -2.46%

Trading Activity for Pfizer Inc

Fund / Manager Click to search
Action Change Shares After Value Price
2026-Q2
BUY +33.1% 3.8M $92M $26.14
BUY +0.1% 1.9M $46M $26.14
BUY +5.3% 1.0M $25M $26.14
SELL -4.3% 464.0K $11M $26.14
BUY NEW 231.0K $6M $26.14
SELL -7.1% 174.6K $4M $26.14
2026-Q1
BUY NEW 2.9M $81M $26.77
SELL -8.5% 1.9M $54M $26.77
BUY +11.2% 990.9K $28M $26.77
SELL -12.5% 484.7K $14M $26.77
BUY +7.2% 187.9K $5M $26.77
2025-Q4
BUY +0.9% 2.1M $52M $25.06
SELL -21.7% 554.0K $14M $25.06
SELL -19.1% 175.3K $4M $25.06
2025-Q3
BUY +5.5% 2.1M $53M $24.65
BUY +36.9% 890.9K $23M $24.65
SELL -3.3% 707.1K $18M $24.65
SELL -7.7% 216.6K $6M $24.65
2025-Q2
SELL -3.0% 2.0M $48M $23.32
SELL -0.6% 731.0K $18M $23.32
SELL -2.9% 234.6K $6M $23.32
2025-Q1
BUY +10.4% 2.0M $51M $26.22
SELL -3.4% 735.2K $19M $26.22
SELL -24.5% 241.6K $6M $26.22
2024-Q4
SELL EXIT $26.71
SELL -17.1% 1.8M $49M $26.71
SELL -23.7% 761.1K $20M $26.71
BUY +41.2% 650.9K $17M $26.71
BUY +38.5% 320.0K $8M $26.71
2024-Q3
SELL -3.1% 2.7M $80M $29.01
BUY +10.4% 2.2M $64M $29.01
SELL -0.5% 997.0K $29M $29.01
SELL -0.0% 231.1K $7M $29.01
2024-Q2
BUY +10.9% 2.8M $79M $27.74
BUY NEW 2.0M $56M $27.74
SELL -2.0% 1.0M $28M $27.74
SELL -0.4% 231.2K $6M $27.74
2024-Q1
BUY +57.9% 2.6M $71M $27.62
SELL -0.3% 1.0M $28M $27.62
BUY +23.6% 232.1K $6M $27.62
2023-Q4
SELL -2.8% 1.6M $47M $30.19
SELL -2.9% 1.0M $30M $30.19
BUY NEW 187.8K $5M $30.19
SELL EXIT $30.19
2023-Q3
SELL -7.1% 1.7M $55M $35.72
SELL -1.0% 1.1M $35M $35.72
BUY NEW 68.0K $2M $35.72
2023-Q2
SELL -26.5% 1.8M $66M $38.75
BUY +3.5% 1.1M $39M $38.75
2023-Q1
BUY +29.7% 2.4M $100M $43.32
SELL -0.8% 1.0M $42M $43.32
2022-Q4
BUY +6.8% 1.9M $96M $48.18
SELL -0.4% 1.0M $53M $48.18
2022-Q3
BUY +46.0% 1.8M $77M $49.27
SELL -0.5% 1.0M $46M $49.27
BUY +15.0% 460.9K $20M $49.27
SELL EXIT $49.27
2022-Q2
SELL -38.6% 1.2M $63M $50.66
BUY +0.5% 1.0M $55M $50.66
2022-Q1
SELL -15.1% 2.0M $102M $52.69
BUY +2.4% 1.0M $54M $52.69
SELL -50.0% 10.0K $518000 $52.69
2021-Q4
BUY +22.2% 2.3M $137M $49.73
BUY +3.8% 1.0M $60M $49.73
SELL EXIT $49.73
BUY +33.3% 20.0K $1M $49.73
2021-Q3
SELL -27.2% 1.9M $81M $44.47
BUY +19.0% 981.0K $42M $44.47
BUY +4.4% 176.5K $8M $44.47
BUY NEW 15.0K $645000 $44.47
2021-Q2
BUY +19.1% 2.6M $102M $39.08
BUY +24.5% 824.5K $32M $39.08
BUY +0.3% 169.1K $7M $39.08
2021-Q1
SELL -2.9% 2.2M $79M $35.47
SELL -1.8% 662.3K $24M $35.47
BUY +33.2% 400.9K $15M $35.47
BUY +55.5% 168.7K $6M $35.47
2020-Q4
SELL EXIT $36.32
SELL -16.6% 2.2M $83M $36.32
SELL -2.6% 674.7K $25M $36.32
BUY NEW 300.9K $11M $36.32
BUY +21.0% 108.5K $4M $36.32
2020-Q3
BUY NEW 3.7M $136M $35.07
SELL -22.6% 2.7M $99M $35.07
SELL -9.4% 692.5K $25M $35.07
SELL -0.1% 89.6K $3M $35.07
2020-Q2
BUY +3.5% 3.5M $114M $34.33
SELL -0.8% 764.5K $25M $34.33
BUY +0.0% 89.7K $3M $34.33
2020-Q1
BUY +46.9% 3.4M $110M $34.64
SELL -4.9% 770.3K $25M $34.64
BUY +7.2% 89.7K $3M $34.64
2019-Q4
BUY NEW 2.3M $90M $35.73
SELL -0.2% 809.8K $32M $35.73
2019-Q3
SELL EXIT $34.94
BUY +0.7% 811.8K $29M $34.94
2019-Q2
SELL -3.8% 3.2M $137M $39.77
BUY +0.7% 806.0K $35M $39.77
2019-Q1
SELL -0.2% 3.3M $140M $40.10
SELL -0.1% 533.6K $23M $40.10
2018-Q4
SELL -38.3% 3.3M $144M $41.58
SELL -0.5% 534.4K $23M $41.58
2018-Q3
SELL -3.7% 5.3M $235M $39.25
SELL -1.8% 537.3K $24M $39.25
2018-Q2
SELL -3.5% 5.5M $201M $34.33
SELL -0.5% 547.0K $20M $34.33
2018-Q1
SELL -1.6% 5.7M $204M $34.54
SELL -0.8% 549.9K $20M $34.54
SELL EXIT $34.54
SELL EXIT $34.54

Insider Trading for Pfizer Inc

No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.